Register for the Joint FDA, MHRA and Health Canada ‘Good Clinical Practice & Pharmacovigilance Compliance Workshop’

Good Clinical Practice and Pharmacovigilance Compliance Workshop 
Tuesday, 13 February to Thursday, 15 February 2024 (EST) 

Bookings are now open for the upcoming hybrid Good Clinical Practice and Pharmacovigilance Compliance Workshop, in partnership with the US Food and Drug Administration (FDA) and Health Canada (HC), presented by CDER Small Business and Industry Assistance (SBIA).  

This workshop will focus on Global Clinical Trials in Good Clinical Practice, Bioequivalence, and Pharmacovigilance in the post pandemic world. Presentations and panel discussions will provide information on the recent updates made to ICH E6(r3) and regulatory perspectives on implementation of proportionate risk-based approaches to the design and conduct of the trial to help ensure that the quality to support good decision making. 

Panellists will discuss continuing developments in novel operational approaches, data sources, and technologies used in clinical trials, as well as novel approaches to regulatory inspections.  

We look forward to welcoming you at the event either: 

• In person at the Hotel at the University of Maryland, College Park, Maryland, USA 
• Virtually online.  

Should you have any queries concerning the event, please email conferences@mhra.gov.uk  

Conferences and Events Team